GENOWAY SA (ALGEN.PA) Stock Earnings & Estimates
EPA:ALGEN - FR0004053510 - Common Stock
2.76 EUR
-0.08 (-2.82%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 17.053M 21.64% | 20.046M 17.55% | 22.059M 10.04% | 22.763M 3.19% | 26.265M 15.38% | 32.96M 25.49% | |
| EBITDA YoY % growth | 3.685M 122.52% | 6.352M 72.36% | N/A -40.01% | 3.09M -18.92% | 3.708M 20.00% | 4.944M 33.33% | |
| EBIT YoY % growth | 949.8K 316.75% | 2.065M 117.45% | 1.812M -12.25% | 618K -65.90% | 412K -33.33% | 1.442M 250.00% | |
| Operating Margin | 5.57% | 10.30% | 8.22% | 2.71% | 1.57% | 4.38% | |
| EPS YoY % growth | N/A | N/A | N/A -50.00% | 0.00 -100.00% | 0.00 | 0.10 |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 11.349M 5.92% | % | ||
| Q2 2024 Q2Q % growth | 10.71M 14.77% | % | ||
| Q4 2023 Q2Q % growth | 10.715M 15.29% | % | ||
| Q2 2023 Q2Q % growth | 9.332M 20.27% | % | ||
| Q4 2022 Q2Q % growth | 9.294M 18.59% | % | ||
| Q2 2022 Q2Q % growth | 7.759M 25.52% | % | ||
| Q4 2021 Q2Q % growth | 7.837M 25.14% | % | ||
| Q2 2021 Q2Q % growth | 6.182M 30.06% | % | ||
| Q4 2020 Q2Q % growth | 6.263M 14.92% | % | ||
| Q2 2020 Q2Q % growth | 4.753M 18.51% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | 0% | 0% |